Qiagen N.V. (QGEN) Financials Nov 14, 2014, 5:17
Qiagen N.V. (QGEN) Financials Nov 14, 2014, 5:17 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Qiagen N.V.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 1.01B 1.09B 1.17B 1.25B 1.3B
Cost of Goods Sold (COGS) incl. D&A 353.25M 371.87M 419.94M 466.55M 470.79M
COGS excluding D&A 232.86M 229.09M 252.56M 268.65M 271.39M
Depreciation & Amortization Expense 120.39M 142.78M 167.38M 197.9M 199.4M
Depreciation 48.58M 57.51M 70.46M 64.8M 72.5M
Amortization of Intangibles 71.82M 85.27M 96.92M 133.1M 126.9M
Gross Income 656.57M 715.56M 749.81M 787.91M 831.2M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 445.55M 503.53M 534.28M 572.69M 617.66M
Research & Development 107.9M 126.04M 125.14M 128.28M 148.17M
Other SG&A 337.65M 377.49M 409.14M 444.42M 469.49M
Other Operating Expense 18.22M 23.49M 26.75M 0 0
Unusual Expense 28.1M 0 72.4M 41M 154.61M
EBIT after Unusual Expense (28.1M) 0 (72.4M) (41M) (154.61M)
Non Operating Income/Expense 30.81M 7.94M (946,000) (7.99M) 6.99M
Non-Operating Interest Income 3.52M 4.46M 6.13M 2.38M 2.3M
Equity in Affiliates (Pretax) 2.94M 0 0 0 0
Interest Expense 29.64M 27.82M 25.36M 23.45M 30.88M
Gross Interest Expense 29.64M 27.82M 25.36M 23.45M 30.88M
Interest Capitalized 0 0 0 0 0
Pretax Income 172.33M 173.12M 96.21M 145.15M 37.34M
Income Tax 34.56M 28.81M 1.26M 15.62M (31.76M)
Income Tax - Current Domestic 12.63M 12.27M 6.75M - -
Income Tax - Current Foreign 32.54M 36.49M 26.37M - -
Income Tax - Deferred Domestic 0 0 - - -
Income Tax - Deferred Foreign (10.61M) (19.94M) (31.86M) - -
Income Tax Credits 0 0 - - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 137.77M 144.31M 94.95M 129.54M 69.1M
Minority Interest Expense 0 0 (1.09M) 31,000 25,000
Net Income 137.77M 144.31M 96.04M 129.51M 69.07M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg - - 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 137.77M 144.31M 96.04M 129.51M 69.07M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 137.77M 144.31M 96.04M 129.51M 69.07M
EPS (Basic) 0.67 0.62 0.41 0.55 0.30
Basic Shares Outstanding 206.93M 232.64M 233.85M 235.58M 234M
EPS (Diluted) 0.64 0.60 0.40 0.54 0.29
Diluted Shares Outstanding 213.61M 240.48M 239.06M 240.75M 242.18M
EBITDA 313.2M 331.32M 356.17M 413.11M 412.94M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Wading into the murky waters of U.S. healthcare insurance isn't for the faint of heart, but Altea's making its move. Backed by MISSION, they're banking on a niche strategy by tapping veteran Justin Rodrick as Vice President. Their tactic? Aim squarely at the under-served segment of small to mid-sized medical and healthcare facilities. The play's bold, and if Rodrick's got...
Continue Reading
Peeking into the Home Care Playbook The process of starting home care isn't some mind-boggling puzzle. For families in Northeastern Pennsylvania, things kick off with a cordial chinwag with a care coordinator—no paperwork chains or Kafkaesque contracts right off the bat. Now, if you've got someone in need of care, this gives you time to shove all your questions onto the...
Continue Reading
The Battle Against Drug Resistance Heats Up Folks, we're in a never-ending fight here against one of the toughest adversaries out there: lung cancer. And lemme tell ya, when drugs show resistance, it's like trying to punch a ghost. But there’s a fresh wind blowing, as Dr. Bobak Parang steps up to the plate with a $620K grant aimed squarely at tackling drug resistance in...
Continue Reading
Deadline Extended for Kenvue's Noteholders In the wild world of corporate finance, the only thing more unpredictable than the weather is a boardroom decision. Kimberly-Clark (NASDAQ: KMB) just threw one such curveball by extending the deadline on their exchange offers for Kenvue Notes to November 2, 2026. Seems like 5 p.m. New York time is the new witching hour for this...
Continue Reading
It's a wild world out there for epilepsy treatments—like a relentless bull run with everyone eyeing the prize. The latest buzz points to a fat 2036 forecast for this sector, driven by a mix of standout technologies and breakthrough therapies. You'd be a fool to blink and miss it. Rising Numbers Stir the Market The numbers, oh boy, they're climbing. In 2025, about 7...
Continue Reading
More Than Just a Debt Guru It's not every day you see a former NFL player shifting gears so smoothly into the corporate world, and then to community service like a missile lock. But that's exactly what Don Silvestri, president of Debt.com, has done. Dragging a hefty reputation as a placekicker for teams like the New York Jets and the Buffalo Bills, he's now making...
Continue Reading
Innovation Meets Organ Donation Out of all the business moves you hear about, this one rings loud because it doesn’t just move the needle on a spreadsheet—it moves the needle on life or death. The Center for Organ Recovery & Education (CORE) is stepping into the future with a high-tech touch to enhance their lifesaving mission. Partnering with InVita Healthcare...
Continue Reading
Bringing the Classics to the Digital Frontier Here's what's lighting a fire under the world of high-end furniture: MillerKnoll's got its eye on the prize by jazzing up Knoll.com with shiny new 3D product configurators. It's like taking a century's worth of design stuffiness and spinning it into the future, ready to dazzle a whole new set of eyeballs. Why This Move Matters...
Continue Reading
Transformations in enterprise management are knocking at the door with Dotwork's latest move. Their strategic acquisition of Arcario Group aims to flip the lid on how companies tie strategies to their daily grind using AI. Let me level with you—this ain't about just spicing up some dashboards or workflows. We're talking about an enterprise-level overhaul in the very way...
Continue Reading
Boeing's Rocky Rollercoaster Ride This Quarter Man, if you want a case study on turbulence in the business world, look no further than Boeing's recent third-quarter performance. This juggernaut managed to clock in $24.2 billion in revenues, up 4% from last year, but it still can't seem to shake off its streak of red ink. We're talking a net loss of $116 million, or a GAAP...
Continue Reading
Top 5 Most Recently Viewed Articles
Bitget Joins the Crypto Jazz Festival in Montreux Bitget, a prominent name in the cryptocurrency exchange and Web3 space, is delighted to announce its collaboration as a primary partner for the inaugural Crypto Jazz Festival. Set against the backdrop of the renowned Montreux Jazz Festival, this innovative event is designed to incorporate the world of cryptocurrency with...
Continue Reading
Compass Diversified Sets Date for Q3 2024 Earnings Release Compass Diversified (NYSE: CODI), located in Westport, Connecticut, has officially announced its plans to unveil the financial results for the third quarter that concluded on September 30, 2024. This announcement is scheduled for a release on Wednesday, October 30, 2024, just after market trading concludes. The...
Continue Reading
US Data to Influence Fed Rate Cut Expectations The US dollar shows a complex performance against its major peers, particularly facing challenges only against the Australian dollar. Recently, the Australian dollar has reached levels not seen in 15 months, showcasing a strong upward trajectory. Despite the ups and downs, market analysts suggest that the dollar’s movements...
Continue Reading
Rémy Martin Celebrates Lunar New Year with Art The renowned House of Rémy Martin proudly announces a remarkable collaboration with celebrated Chinese artist Xue Song to honor the Lunar New Year. This year's theme, inspired by the Year of the Horse, sees Xue Song reinterpreting the iconic Centaur figure associated with Rémy Martin, translating its symbolism into a...
Continue Reading
Exciting Upcoming Events for Trulieve Cannabis Corp Trulieve Cannabis Corp (CSE: TRUL, OTCQX: TCNNF) is making waves in the cannabis sector with its recent announcement regarding its participation in various significant events coming up in the near future. Known for being a leading company in the cannabis market, Trulieve continues to solidify its reputation through...
Continue Reading